The federal agency introduced Elsa last month, boasting about the AI tool's ability to increase efficiency at the FDA.

Two months after laying off 20% of its staff, Korro Bio says it has not retreated from its “3-2-1” corporate strategy as it prepares to release interim clinical data on its lead candidate KRRO-110 in ...

GLP-1 medications, on average, can cost individuals $1,000 per month if their employers do not provide insurance coverage, Andrea Grande, a principal at Brown & Brown, said ...

Heat stroke is a body’s critical call for help. You can die. Temperature rises above 104 degrees — sometimes as high as 108 ...

President Donald Trump’s announcement Wednesday about his plans for artificial intelligence include a push to grow AI ...

TAX TALK — Recent polling shows Michelle Wu crushing the competition in Boston’s mayoral race. Her campaign is still keeping ...

Retailers have left and poor behaviour is a problem but what could help give the area a new lease of life - we ask you.

California government officials are trying to find a buyer for the refinery. Giuliani said that losing the refinery would put ...

On 8 July 2025, the US Department of Justice Antitrust Division (the Division) unveiled a new Whistleblower Rewards Program (the ...

Thankfully, the case against me was purely political, and I had the support of relentless advocates and negotiators who ...

Advocates for single-payer health care say creating a Massachusetts Healthcare Trust could save the state $37.36 billion in ...

Platform was spotlighted by Dr. Amir Horowitz at ASGCT 2025 for its approach to targeting the HLA-E/NKG2A axis to selectively activate NK and CD8+ T cells, potentially addressing treatment resistance.